Olema Pharmaceuticals, Inc. - Common Stock (NQ:OLMA)
Price and Volume
Detailed Quote| Volume | 792,498 |
| Open | 14.38 |
| Bid (Size) | 14.33 (100) |
| Ask (Size) | 14.40 (1,100) |
| Prev. Close | 14.41 |
| Today's Range | 14.15 - 14.61 |
| 52wk Range | 3.890 - 36.26 |
| Shares Outstanding | 54,769,800 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Top stock movements in today's session. ↗
March 09, 2026
Monday's session: top gainers and losers ↗
March 09, 2026
Wondering what's happening in today's pre-market session? ↗
March 09, 2026
Olema Oncology to Participate in Upcoming Investor Conferences
February 04, 2026
Olema Insider Sells $8 Million in Shares After 300% Stock Surge ↗
January 09, 2026
Frequently Asked Questions
Is Olema Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Olema Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Olema Pharmaceuticals, Inc. - Common Stock trade on?
Olema Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Olema Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Olema Pharmaceuticals, Inc. - Common Stock is OLMA on the Nasdaq Stock Market
What is the current price of Olema Pharmaceuticals, Inc. - Common Stock?
The current price of Olema Pharmaceuticals, Inc. - Common Stock is 14.32
When was Olema Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Olema Pharmaceuticals, Inc. - Common Stock was at 05/01/26 04:00 PM ET
What is the market capitalization of Olema Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Olema Pharmaceuticals, Inc. - Common Stock is 784.30M
How many shares of Olema Pharmaceuticals, Inc. - Common Stock are outstanding?
Olema Pharmaceuticals, Inc. - Common Stock has 784M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.